Village Farms Intlの空売り状況は、投資家がVillage Farms Intlの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Village Farms Intl (NASDAQ:VFF) 株価情報, 空売り情報

Village Farms Intl

Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The Company has identified four operating segments - Produce, Cannabis-Canada, Cannabis-U.S. and Energy. The company makes majority of its revenue from the Produce segment.

Village Farms International, Inc. - Common Shares

Village Farms International Inc

Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.10) by 30 percent. This is a 41.67 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $190.00 thousand which missed the analyst consensus estimate of $2.25 million by 91.56 percent. This is a 81.85 percent decrease over sales of $1.05 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

MVIS

Microvision Q3 EPS $(0.07) Beats $(0.10) Estimate, Sales $190.00K Miss $2.25M Estimate

At current rates, the Company expects negligible year-over-year currency impact on the full year 2024 revenues.
Additionally, Artivion continues to expect adjusted EBITDA growth of between 28% and 34% for the full year 2024 compared to 2023 resulting in an expected range of $69 to $72 million for 2024.

Guidance

AORT

Artivion Narrows FY24 Revenue Outlook From $388M -$396M To $389M - $396M, Est $391.955M

Sprout Social (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPT#NASDAQ">SPT</a>) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.12 by 8.33 percent. The company reported quarterly sales of $102.638 million which beat the analyst consensus estimate of $102.001 million by 0.62 percent. This is a 20.00 percent increase over sales of $85.532 million the same period last year.

Sprout Social Q3 2024 Adj. EPS $0.13 Beats $0.12 Estimate, Sales $102.638M Beat $102.001M Estimate

W&amp;T Offshore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTI#NYSE">WTI</a>) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. The company reported quarterly sales of $121.372 million which missed the analyst consensus estimate of $122.406 million by 0.84 percent. This is a 14.77 percent decrease over sales of $142.411 million the same period last year.

W&T Offshore Q3 2024 Adj. EPS $(0.17) Beats $(0.19) Estimate, Sales $121.372M Miss $122.406M Estimate

Arcellx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACLX#NASDAQ">ACLX</a>) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.37) by 29.73 percent. The company reported quarterly sales of $26.03 million which missed the analyst consensus estimate of $34.37 million by 24.26 percent. This is a 74.03 percent increase over sales of $14.96 million the same period last year.

ACLX

Arcellx Q3 2024 GAAP EPS $(0.48) Misses $(0.37) Estimate, Sales $26.03M Miss $34.37M Estimate

Management

Natural Gas Services Group Announced The Appointment Of Ian Eckert As CFO Effective No Later Than January 5th, 2026. NGS's Current Interim CFO John Bittner Will Continue In that Role Until Mr. Eckert's Start Date

Con Edison CFO Kirk Andrews Says We Are Narrowing And Revising Our 2024 Adjusted EPS Guidance To The Upper Half Of Our Original Range

Cambium Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMBM#NASDAQ">CMBM</a>) sees Q4 sales of $40.000 million-45.000 million vs $50.03 million estimate.

CMBM

Cambium Networks Sees Q4 Sales $40.000M-45.000M vs $50.03M Est

SEMrush Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEMR#NYSE">SEMR</a>) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.03 by 66.67 percent. The company reported quarterly sales of $97.400 million which beat the analyst consensus estimate of $96.647 million by 0.78 percent. This is a 23.73 percent increase over sales of $78.718 million the same period last year.

SEMR

SEMrush Hldgs Q3 2024 GAAP EPS $0.01 Misses $0.03 Estimate, Sales $97.400M Beat $96.647M Estimate

Sandstorm Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAND#NYSE">SAND</a>) reported quarterly sales of $44.700 which missed the analyst consensus estimate of $44.900 million by 100.00 percent. This is a 100.00 percent decrease over sales of $41.324 million the same period last year.

SAND

Sandstorm Gold Q3 Sales $44.700 Miss $44.900M Estimate

nLight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LASR#NASDAQ">LASR</a>) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $56.13 million which beat the analyst consensus estimate of $55.27 million by 1.55 percent. This is a 10.85 percent increase over sales of $50.63 million the same period last year.

LASR

nLight Q3 Adj $(0.08), Inline, Sales $56.13M Beat $55.27M Estimate

Lumentum Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITE#NASDAQ">LITE</a>) is looking for Q2 Adj EPS of $0.30-0.40 vs $0.27 analyst estimate. sees sales of $380.000 million-400.000 million vs $354.32 million estimate.

LITE

Lumentum Holdings Sees Q2 Adj EPS $0.30-0.40 vs $0.27 Est; Sees Sales $380.000M-400.000M vs $354.32M Est

Consolidated Edison (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ED#NYSE">ED</a>) reported quarterly earnings of $1.68 per share which beat the analyst consensus estimate of $1.62 by 3.7 percent.

Consolidated Edison Q3 2024 Adj. EPS $1.68 Beats $1.62 Estimate

PDF Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDFS#NASDAQ">PDFS</a>) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $0.20 by 25 percent. The company reported quarterly sales of $46.409 million which beat the analyst consensus estimate of $46.196 million by 0.46 percent. This is a 9.58 percent increase over sales of $42.350 million the same period last year.

PDFS

PDF Solutions Q3 2024 Adj. EPS $0.25 Beats $0.20 Estimate, Sales $46.409M Beat $46.196M Estimate

TELA Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TELA#NASDAQ">TELA</a>) affirms FY2024 sales outlook from $74.50 million-76.50 million to $74.50 million-76.50 million.

TELA

TELA Bio Affirms FY2024 Sales Guidance from $74.50M-76.50M to $74.50M-76.50M

Iovance Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) affirms FY2025 Product sales outlook from $450.00 million-475.00 million to $450.00 million-475.00 million.

IOVA

Iovance Biotherapeutics Affirms FY2025 Product Sales Guidance from $450.00M-475.00M to $450.00M-475.00M

Collegium Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLL#NASDAQ">COLL</a>) raises FY2024 sales outlook from $580.00 million-595.00 million to $620.00 million-635.00 million.

COLL

Collegium Pharmaceutical Raises FY2024 Sales Guidance from $580.00M-595.00M to $620.00M-635.00M  VS Est.625.37M

CPAY

Corpay Expects Q4 Total Revenues Of $1.04B - $1.07B, Adjusted EP Of $5.25 - $5.45

Iovance Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) affirms FY2024 Product sales outlook from $160.00 million-165.00 million to $160.00 million-165.00 million.

Iovance Biotherapeutics Affirms FY2024 Product Sales Guidance from $160.00M-165.00M to $160.00M-165.00M

AerSale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASLE#NASDAQ">ASLE</a>) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.05 by 20 percent. This is a 33.33 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $82.68 million which missed the analyst consensus estimate of $92.83 million by 10.93 percent. This is a 10.60 percent decrease over sales of $92.48 million the same period last year.

ASLE

AerSale Q3 Adj $0.04 Misses $0.05 Estimate, Sales $82.68M Miss $92.83M Estimate

Village Farms International (VFF) has released an update. Village Farms International, a leader in controlled environment agriculture, has announce...

Village Farms International to Speak at Cannabis Conference

Village Farms Offers Cannabis Investors A Fantastic Opportunity

Village Farms International receives Nasdaq non-compliance notification

Village Farms International (VFF) has released an update. Village Farms International has received a notification from Nasdaq that its stock price ...

Village Farms Faces Nasdaq Compliance Challenge

Tilray Brands Is Still Priced Too High

Village Farms (VFF) was one of 25 participants selected to participate in the Drug Enforcement Administration's upcoming Administrative Law Judge h...

Village Farms to testify at marijuana rescheduling hearing

Village Farms International (VFF) has released an update. Village Farms International has been selected as the sole cannabis industry operator to p...

Village Farms to Testify at DEA Marijuana Hearing

Village Farms GAAP EPS of -$0.01 beats by $0.02, revenue of $83.37M beats by $2.8M

In a report released today, Eric Des Lauriers from Craig-Hallum maintained a Buy rating on Village Farms International (VFF – Research Report). The...

Comments

Village Farms Intl

空売り

Village Farms Intl (NASDAQ:VFF) 株価情報, 空売り情報

ニュース

パートナーシップ

ベンジンガ・グローバル